Loading...
AFJKR
XNAS
Market cap37mUSD
Nov 20, Last price  
0.10USD
1D
0.00%
1Q
-25.41%
IPO
-50.00%
Name

Aimei Health Technology Co Ltd

Chart & performance

D1W1MN
XNAS:AFJKR chart
Shares per right
Share price
11.78
Intrinsic value
Premium
Underlying
AFJKXNAS
Converts
On combination

Right terms

Terms

Kind
Underlying share
Shares per right

Dates

Issue date
Converts

Issue

Rights issued
From unit
per AFJKU

Documents

424B4 Prospectus, Dec 05, 2023 terms
8-A12B Exchange registration of securities, Nov 30, 2023 terms

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Aimei Health Technology Co., Ltd. currently lacks substantial business operations. Its core purpose is to pursue a strategic business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more companies. The firm intends to acquire businesses operating in the biopharmaceutical, medical technology/device, diagnostic, and other service-related industries. Aimei Health Technology Co., Ltd. was established in 2023 and is based in New York, New York.

Key people

Junheng Xie
Chief Executive Officer, Company Secretary, Director · since 2024
Heung Ming Wong
Chief Financial Officer, Director · since 2023
Lin Bao
Independent Director
Julianne Huh
Independent Director · since 2021
Robin Karlsen
Independent Director · since 2022
IPO date
Jan 22, 2024
Domiciled in
US
Incorporated in
KY

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFY
2025‑122024‑122023‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT